Correlation Between Emergent Biosolutions and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on Emergent Biosolutions and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Telomir Pharmaceuticals,.

Diversification Opportunities for Emergent Biosolutions and Telomir Pharmaceuticals,

0.09

Correlation Coefficient

Emergent Biosolutions  Telomir Pharmaceuticals,

Significant diversification

The 3 months correlation between Emergent and Telomir is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Telomir Pharmaceuticals,

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Telomir Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Emergent Biosolutions is 1.01 times less risky than Telomir Pharmaceuticals,. The stock trades about -0.48 of its potential returns per unit of risk. The Telomir Pharmaceuticals, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  417.00  in Telomir Pharmaceuticals, Common on December 4, 2024 and sell it today you would lose (7.00) from holding Telomir Pharmaceuticals, Common or give up 1.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Telomir Pharmaceuticals, Commo

Emergent Biosolutions

Risk-Adjusted Performance

Very Weak

Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Emergent Biosolutions and Telomir Pharmaceuticals,

The main advantage of trading using opposite Emergent Biosolutions and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind Emergent Biosolutions and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.